Patient Participation and the Use of Ehealth Tools for Pharmacoviligance
- PMID: 27148052
- PMCID: PMC4827142
- DOI: 10.3389/fphar.2016.00090
Patient Participation and the Use of Ehealth Tools for Pharmacoviligance
Abstract
In recent years, pharmacovigilance has undergone some major changes. First, the patient's active role in identifying and describing adverse drug reactions (ADRs) has gained recognition. Second, pharmacovigilance has increasingly incorporated information and communications technology (ICT). Patients can now upload their own reports of ADRs online. Data on intensive medication monitoring are now collected via the Internet and smartphones. Worldwide collection of AEs using smart phones might become the leading technique in Low and Middle Income Countries where broad mobile phone service can be managed cheaper than Internet communication. At the same time, researchers are exploring the potential for data sharing via online forums and Internet search engines. In particular we synthetize the Pros and cons of the various methods for gathering pharmacovigilance data (i.e., Web-based spontaneous reporting of adverse drug reactions; Intensive drug monitoring studies; Analysis of online forum postings; Use of mobile phone systems to monitor drug effects). This article describes these advances and highlights their respective contributions.
Keywords: adverse drug reactions; adverse events; ehealth; intensive medication monitoring; mobile apps; patient participation; pharmacovigilance; web-based reporting.
Similar articles
-
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200. Health Technol Assess. 2011. PMID: 21545758 Review.
-
Web-based intensive monitoring: from passive to active drug surveillance.Expert Opin Drug Saf. 2012 Jan;11(1):45-51. doi: 10.1517/14740338.2012.629184. Epub 2011 Oct 18. Expert Opin Drug Saf. 2012. PMID: 22007719 Review.
-
Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions.Front Pharmacol. 2018 May 1;9:439. doi: 10.3389/fphar.2018.00439. eCollection 2018. Front Pharmacol. 2018. PMID: 29765326 Free PMC article.
-
Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.Therapie. 2014 Sep-Oct;69(5):395-400. doi: 10.2515/therapie/2014035. Epub 2014 Oct 1. Therapie. 2014. PMID: 25269141
-
Spontaneous adverse drug reaction reporting by patients in Canada: a multi-method study-study protocol.Springerplus. 2016 Feb 29;5:213. doi: 10.1186/s40064-016-1838-9. eCollection 2016. Springerplus. 2016. PMID: 27026907 Free PMC article.
Cited by
-
Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries.Int J Environ Res Public Health. 2022 Apr 7;19(8):4447. doi: 10.3390/ijerph19084447. Int J Environ Res Public Health. 2022. PMID: 35457318 Free PMC article. Review.
-
Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making.Drug Saf. 2024 Mar;47(3):217-225. doi: 10.1007/s40264-023-01385-2. Epub 2023 Dec 11. Drug Saf. 2024. PMID: 38082120
-
Effectiveness of the modified TaWai mobile application for reporting adverse drug reaction in Lao PDR: a cluster randomized controlled trial.Sci Rep. 2024 Dec 28;14(1):31161. doi: 10.1038/s41598-024-82474-9. Sci Rep. 2024. PMID: 39730897 Free PMC article. Clinical Trial.
-
A patient-centred web-based adverse drug reaction reporting system identifies not yet labelled potential safety issues.Eur J Clin Pharmacol. 2021 Nov;77(11):1697-1704. doi: 10.1007/s00228-021-03134-9. Epub 2021 Jun 18. Eur J Clin Pharmacol. 2021. PMID: 34143228 Free PMC article.
-
Thai stakeholders' awareness and perceptions of the patient adverse event reporting system for herbal medicines: a qualitative study.Int J Clin Pharm. 2023 Apr;45(2):491-501. doi: 10.1007/s11096-022-01533-1. Epub 2023 Feb 6. Int J Clin Pharm. 2023. PMID: 36745312 Free PMC article.
References
-
- Adams S. A. (2013). Using patient-reported experiences for pharmacovigilance? Stud. Health Technol. Inform. 194 63–68. - PubMed
-
- Adedeji A. A., Sanusi B., Tella A., Akinsanya M., Ojo O., Akinwunmi M. O., et al. (2011). Exposure to anti-malarial drugs and monitoring of adverse drug reactions using toll-free mobile phone calls in private retail sector in Sagamu, Nigeria: implications for pharmacovigilance. Malar. J. 10 230 10.1186/1475-2875-10-230 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous